438 related articles for article (PubMed ID: 9440541)
1. Heterogeneity of mast cells in mastocytosis and inhibitory effect of ketotifen and ranitidine on indolent systemic mastocytosis.
Kurosawa M; Amano H; Kanbe N; Akimoto S; Takeuchi Y; Yamashita T; Hashimoto T; Kurimoto F; Miyachi Y
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S25-32. PubMed ID: 9440541
[TBL] [Abstract][Full Text] [Related]
2. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
3. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis.
Granerus G; Lönnqvist B; Roupe G
Agents Actions; 1994 Jun; 41 Spec No():C127-8. PubMed ID: 7526641
[TBL] [Abstract][Full Text] [Related]
4. Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis.
Kurosawa M; Amano H; Kanbe N; Igarashi Y; Nagata H; Yamashita T; Kurimoto F; Miyachi Y
J Allergy Clin Immunol; 1999 May; 103(5 Pt 2):S412-20. PubMed ID: 10329843
[TBL] [Abstract][Full Text] [Related]
5. Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis.
Pehlivanidis C; Fotoulaki M; Boucher W; Kempuraj D; Pang X; Konstantinidou A; Theoharides TC
J Clin Psychopharmacol; 2002 Apr; 22(2):221-4. PubMed ID: 11910271
[No Abstract] [Full Text] [Related]
6. Mastocytosis in infants and children: recognition of patterns of skin disease.
Kirshenbaum AS; Kettelhut BV; Metcalfe DD; Garriga MM
Allergy Proc; 1989; 10(1):17-21. PubMed ID: 2925086
[TBL] [Abstract][Full Text] [Related]
7. Mast-cell phenotype in indolent forms of mastocytosis. Ultrastructural features, fluorescence detection of avidin binding, and immunofluorescent determination of chymase, tryptase, and carboxypeptidase.
Weidner N; Horan RF; Austen KF
Am J Pathol; 1992 Apr; 140(4):847-57. PubMed ID: 1562049
[TBL] [Abstract][Full Text] [Related]
8. The skin in mastocytosis.
Soter NA
J Invest Dermatol; 1991 Mar; 96(3):32S-38S; discussion 38S-39S. PubMed ID: 1672136
[TBL] [Abstract][Full Text] [Related]
9. Chronically KIT-stimulated clonally-derived human mast cells show heterogeneity in different tissue microenvironments.
Longley BJ; Tyrrell L; Lu S; Ma Y; Klump V; Murphy GF
J Invest Dermatol; 1997 May; 108(5):792-6. PubMed ID: 9129234
[TBL] [Abstract][Full Text] [Related]
10. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study.
Horny HP; Greschniok A; Jordan JH; Menke DM; Valent P
J Clin Pathol; 2003 Feb; 56(2):103-6. PubMed ID: 12560387
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas.
Haas N; Hamann K; Grabbe J; Algermissen B; Czarnetzki BM
Arch Dermatol Res; 1995; 287(3-4):242-8. PubMed ID: 7541189
[TBL] [Abstract][Full Text] [Related]
12. Serum tryptase measured with B12 and G5 antibody-based immunoassays in mastocytosis patients and its relation to histamine turnover.
Granerus G; Lönnqvist B; Nystrand J; Roupe G
Br J Dermatol; 1998 Nov; 139(5):858-61. PubMed ID: 9892955
[TBL] [Abstract][Full Text] [Related]
13. [Vulvar oedema revealing systemic mastocytosis].
Deveza E; Locatelli F; Girardin M; Valmary-Degano S; Daguindau E; Aubin F; Humbert P; Pelletier F
Ann Dermatol Venereol; 2015 Nov; 142(11):685-9. PubMed ID: 26003033
[TBL] [Abstract][Full Text] [Related]
14. Diffuse erythrodermic cutaneous mastocytosis with bone marrow infiltration.
Olgun N; Oren H; Oren B; Irken G; Polat M; Cevik N
Dermatology; 1993; 187(2):127-9. PubMed ID: 8358101
[TBL] [Abstract][Full Text] [Related]
15. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
[TBL] [Abstract][Full Text] [Related]
16. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
[TBL] [Abstract][Full Text] [Related]
17. A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val.
Jordan JH; Fritsche-Polanz R; Sperr WR; Mitterbauer G; Födinger M; Schernthaner GH; Christian Bankl H; Gebhart W; Chott A; Lechner K; Valent P
Leuk Res; 2001 Jul; 25(7):627-34. PubMed ID: 11377687
[TBL] [Abstract][Full Text] [Related]
18. Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase.
Brockow K; Akin C; Huber M; Scott LM; Schwartz LB; Metcalfe DD
J Allergy Clin Immunol; 2002 Jan; 109(1):82-8. PubMed ID: 11799370
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Mastocytosis With Atypical Mast Cells in a 7-Year-Old Girl.
Marrero Alemán G; El Habr C; Islas Norris D; Montenegro Dámaso T; Borrego L; Sangueza OP
Am J Dermatopathol; 2017 Apr; 39(4):310-312. PubMed ID: 28328617
[TBL] [Abstract][Full Text] [Related]
20. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.
Schwartz LB; Sakai K; Bradford TR; Ren S; Zweiman B; Worobec AS; Metcalfe DD
J Clin Invest; 1995 Dec; 96(6):2702-10. PubMed ID: 8675637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
